What Is TEHR? The Platform Behind Your Health Brand

What problem does TEHR solve?

A health brand needs more than a website that accepts payments. Someone must collect intake information, route it to the appropriate clinician, coordinate prescriptions when appropriate, connect pharmacy fulfillment, manage recurring billing and keep customers informed. These steps become harder to operate when every system has a different patient identifier, status definition and support contact.

TEHR brings those business and care-administration workflows together. The point is to reduce the amount of infrastructure a brand must assemble and maintain before it can serve customers. Read the TEHR platform overview with that operating problem in mind: the important question is whether your team can understand what happens next when a patient, payment or order needs attention.

That matters for both new founders and established operators. A creator may already have audience trust but no healthcare operating stack. An existing telehealth brand may have patients and revenue but want a different platform. Both need a clear assignment of responsibilities before launch.

What does the platform include?

TEHR connects branded patient experiences, AI-assisted intake, access to an independent licensed clinical network with 50-state reach, clinician-led e-prescribing, pharmacy coordination, payments, subscriptions and patient-support workflows. The actual proposal defines included services, available programs and support coverage. Network reach does not mean every treatment is offered to every person in every state.

Ask to see a routine journey and an exception journey. A successful payment followed by a clinician declining treatment, for example, reveals how the system handles communication, refunds and next steps. That is more informative than watching a dashboard update under ideal conditions.

Who owns the brand and who provides the care?

Your brand owns its identity and commercial positioning, subject to its agreements and applicable law. Patients experience the service under that identity. Required notices still need to identify the real clinical, pharmacy and other relevant entities; white-label presentation should never obscure who is responsible for care.

Independent licensed providers evaluate patients and make clinical decisions. TEHR does not practice medicine or prescribe. The distinction is practical: the brand can choose its audience, design an onboarding experience and set commercial goals, but it cannot require a clinician to approve an unsuitable treatment.

The Medical Board of California’s corporate-practice guidance illustrates why administrative ownership and clinical control must be separated. Rules vary by jurisdiction. Our guide to medical licensing and brand ownership explains the questions to resolve with qualified counsel before choosing a structure.

How is TEHR different from an ordinary EHR?

An electronic health record organizes clinical documentation. A direct-to-consumer brand also has to connect acquisition, identity, payments, subscriptions, communication and fulfillment. These are related problems, but a record system alone does not necessarily solve the entire operating problem.

TEHR’s campaign line, “The EHR is dead. Long live TEHR,” expresses that broader ambition. It does not mean medical records are obsolete or that documentation obligations disappear. Reliable clinical records remain essential. The operating platform has to make those records available to the people authorized to use them while connecting the surrounding business workflows.

Evaluate the platform from the perspective of each team. A support coordinator needs a clear next step without unnecessary access to sensitive information. A clinician needs relevant history and clinical context. A finance operator needs understandable transaction events. The white-label telehealth definition explains how those layers fit into the broader category.

What does AI do inside this model?

AI-assisted intake and chart preparation help organize information for the care team. The purpose is to reduce repetitive administrative work and make the workflow easier to navigate. AI assistance does not turn a questionnaire into a prescription or replace the clinician’s responsibility to evaluate the patient.

A useful demonstration starts with the original patient information, shows what the software organized, and explains what a clinician can review or correct. Ask how incomplete answers, conflicting information and changes in a patient’s circumstances reach a human. The response should describe an operating process, not simply name a model or display an AI badge.

Also separate administrative automation from clinical judgment. Appointment reminders, status updates and subscription events may be suitable for automation under defined rules. Decisions about diagnosis, appropriateness of treatment and prescribing remain with independent licensed providers. Ask which functions are available today, which require configuration and which fall outside the proposed service.

How does TEHR make money?

TEHR uses a flat platform subscription plus a flat transaction fee, with 0% revenue share. Contact TEHR for a scoped quote. The fee structure should be evaluated alongside the complete cost of operating the proposed program, including relevant clinical, pharmacy, laboratory, processing and support charges.

Zero revenue share is a pricing characteristic, not a promise that all other services are free or that a brand will be profitable. Operators still need to understand what triggers each charge, which costs recur, and how refunds or unsuccessful journeys are handled. A transaction fee should have a written definition that matches the events in the actual workflow.

Use the pricing page to start that discussion, then model the assumptions in the TEHR pricing calculator. The cost guide explains how to compare a platform quote with the total operating budget rather than a single headline number.

Can an existing brand move patients to TEHR?

Yes, TEHR supports scoped patient migration projects. The team was built by operators behind DudeMeds, Peptiders, TellyMeds and FansMeds, who migrated thousands of their own patients onto the platform. That experience supports a practical migration discussion; it is not a universal time guarantee for every source system or patient population.

A migration includes more than importing a contact list. It can involve historical clinical records, active orders, pending lab work, subscription schedules, patient communications and ongoing access to the previous system. Payment credentials and clinical records may follow different transfer processes. Both need named owners and acceptance criteria.

Start with the migration overview and the patient migration checklist. Bring a data inventory, a description of active programs and your current contract constraints. Those inputs make it possible to discuss a realistic sequence, including a pilot cohort and a plan for exceptions.

Which care categories can a brand explore?

Brands can discuss supported programs across areas such as men’s health, women’s health, dermatology, hair loss, sexual health, longevity and weight management. Actual availability depends on the program, patient location, clinical assessment and pharmacy requirements. A category label is the start of a scoping conversation, not a blanket commitment to a medication list.

Selected peptide programs remain pending and are not open for prescribing or fulfillment. See the peptide program status before making any customer-facing claim. Infrastructure readiness does not itself establish that a particular product may launch, and a policy headline is not a substitute for product-specific review.

Lab workflows also need a defined service model. Ordering, collection, testing, results and follow-up are separate responsibilities. A brand interested in diagnostics should discuss the actual partner arrangement and available services rather than infer that a full standalone lab-brand product is included in every platform plan.

What should you bring to a TEHR evaluation?

Bring the audience you want to serve, the care categories you are considering, your intended launch states and a realistic view of your operating team. If you already have patients, bring a summary of current systems, renewals, open orders and support volume. Use aggregate descriptions first; sensitive patient data belongs in an agreed secure process.

Ask for a written responsibility map covering the brand, TEHR, clinical entities, pharmacy partners and any laboratory partners. Then walk through approval, decline, failed payment, delayed fulfillment, cancellation and escalation scenarios. Each should end with a clear owner, patient message and observable system status.

Finally, agree on what success means before committing. A launch might require tested journeys and trained support staff; a migration also needs record reconciliation and continuity checks. Browse the TEHR resource library to prepare specific questions. The strongest buying decision is based on a service scope your team can actually operate.

What else should you know?